Subject Area
Endocrinology
Article Type
Original Study
Abstract
Background: Cyclooxygenase-2 (COX-2) is an enzyme responsible for the conversion of arachidonic acid into prostaglandins. Despite previous studies, there is controversy considering the exact role of COX-2 in the pathogenesis of type 2 diabetes mellitus (T2DM) and its related adverse cardiovascular events. We aimed to examine the association between COX-2 rs20417 genetic polymorphism with increasing susceptibility to T2DM and whether it enhances the development of cardiovascular complications in T2DM. Methods: A total of 244 individuals were recruited, including 164 T2DM patients (further subdivided into uncomplicated and cardio-complicated cases) and 80 healthy control subjects. The different genotypes for the COX-2 rs20417 polymorphism were assayed through polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Lipid profile and oxidative stress markers (oxidized LDL (OX-LDL) and malonaldehyde (MDA)) were assayed. Results: The CC, GC, and GC+CC variants of the COX-2 rs20417 polymorphism were significantly more prevalent in T2DM group compared with the healthy control group (P
Recommended Citation
Mourad, Shereen A.; El Arman, Mohammed M.; Mesbah, Abeer; Youssef, Amany R.; Gouda, Tarek; Nada, Hyam Sameh; and El-Hanafy, Doaa A.
(2025)
"Cyclooxygenase-2 Gene Variant in Egyptian Patients with Type 2 Diabetes Mellitus with Correlation to Lipid Profile and Markers of Oxidative Stress,"
Mansoura Medical Journal: Vol. 55
:
Iss.
1
, Article 4.
Available at:
https://doi.org/10.58775/2735-3990.1494
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.


